AXT, Inc. is a Fremont, California-based materials science company that designs, develops, manufactures, and distributes compound and single-element semiconductor substrates — wafers used where standard silicon cannot meet performance requirements. Its core products include indium phosphide (InP), gallium arsenide (GaAs), and germanium (Ge) substrates. Indium phosphide is especially critical for the optical transceivers and silicon-photonics components used in AI data-center connectivity, a market that has become AXT's primary growth engine. Manufacturing is largely carried out through its Chinese subsidiary, Tongmei, across three facilities in Beijing, with sales, administration, and customer service based in Fremont. AXT's vertically integrated supply chain and proprietary crystal-growth technology are key competitive strengths. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Over the last 30 days, AXT shares rose about 50%, from a closing price of $48.83 on July 20 to $73.43 on August 19. The advance was not linear: shares spiked immediately after the July 30 earnings report and pushed toward a mid-August high above $95 before pulling back.
The last quarter tells a different story. Over the trailing three-month period, the stock is still down roughly 35% from about $113 per share in mid-May. After peaking near $141 on May 22, shares sold off sharply to a late-July trough near $37 on July 29 before the earnings-driven rebound. In other words, the 30-day gain represents a recovery from a deeply oversold base rather than a fresh record high. One thing that stands out here is how quickly sentiment shifted with the fundamentals.
The dominant catalyst was AXT's second-quarter 2026 report, released after the market close on July 30. The company posted record revenue of $47.6 million, up 164% year over year, with indium phosphide revenue reaching a record of roughly $30.7 million. Gross margin expanded to about 45% from 8.2% a year earlier, and the company swung to net income of $11.1 million. Non-GAAP earnings per share of $0.19 compared with a consensus estimate near $0.07, and shares jumped more than 50% in after-hours trading.
Forward guidance added further fuel. Management guided third-quarter non-GAAP EPS of $0.30 to $0.32 on revenue of roughly $66 million, a sharp step-up from prior expectations. AXT also announced a long-term indium phosphide supply and capacity-reservation agreement with Lumentum (LITE) supported by $87.5 million in deposits applied as shipment credits through 2031, and disclosed an indium phosphide backlog above $100 million. Several analysts raised targets after the report, with published price targets ranging from $55 to $125. I’m watching this closely because the backlog visibility is unusual for the sector.
AXT's quarterly trajectory has been exceptionally volatile. In May, the stock reached roughly $141 as investors bid up the AI-optical-connectivity theme, driving the shares to extreme gains for the year. The subsequent selloff reflected valuation concerns — with the stock trading at a price-to-sales multiple far above historical norms — along with profit-taking and renewed focus on execution risk, particularly the timing of Chinese export permits for indium phosphide shipments and U.S. tariff exposure. The July 30 earnings report reversed the downtrend by showing fundamentals catching up to the AI narrative, but shares remain below the May peak as investors weigh whether the growth is sustainable.
Tickeron operates hundreds of AI-powered trading bots that collectively trade thousands of tickers, but only the top-performing and most relevant strategies are featured in its curated Trending AI Robots section. The bots vary widely in strategy, holding timeframe, and performance metrics, giving traders a way to compare automated approaches side by side. For investors watching high-volatility semiconductor names like AXTI, this section provides a useful starting point for exploring how AI-driven strategies are currently positioned across the market.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.
The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.
The Aroon Indicator entered an Uptrend today. In of 247 cases where AXTI Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The 10-day RSI Indicator for AXTI moved out of overbought territory on August 18, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 34 similar instances where the indicator moved out of overbought territory. In of the 34 cases, the stock moved lower in the following days. This puts the odds of a move lower at .
The Momentum Indicator moved below the 0 level on August 20, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on AXTI as a result. In of 82 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
The Moving Average Convergence Divergence Histogram (MACD) for AXTI turned negative on August 24, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 45 similar instances when the indicator turned negative. In of the 45 cases the stock turned lower in the days that followed. This puts the odds of success at .
AXTI moved below its 50-day moving average on August 28, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for AXTI crossed bearishly below the 50-day moving average on September 03, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where AXTI declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
AXTI broke above its upper Bollinger Band on August 07, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. AXTI’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AXTI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 66, placing this stock worse than average.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.575) is normal, around the industry mean (7.631). AXTI's P/E Ratio (2054.667) is considerably higher than the industry average of (145.346). AXTI's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.132). AXTI has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.006). P/S Ratio (25.510) is also within normal values, averaging (28.309).
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a manufactures of high-performance compound semiconductor substrates
Industry ElectronicProductionEquipment